Outcome measures | Screening | Baseline | Treatment (weeks 1–8) | Follow-up (weeks 9–16) | ||
---|---|---|---|---|---|---|
Week 4 | Week 8 | Week 12 | Week 16 | |||
VAS for lower back pain | ◎ | ◎ | ◎ | ◎ | ◎ | ◎ |
VAS for radiating pain | ◎ | ◎ | ◎ | ◎ | ◎ | |
ODI | ◎ | ◎ | ◎ | ◎ | ◎ | |
RMDQ | ◎ | ◎ | ◎ | ◎ | ◎ | |
EQ-5D-5 L | ◎ | ◎ | ◎ | ◎ | ◎ | |
GPE | ◎ | ◎ | ◎ | ◎ | ||
Assessment of binding | ◎ | |||||
Adverse eventsa | ◎ | ◎ | ◎ | ◎ | ◎ |